MetLife Inc. stock (US59156R1086): preferred ex-dividend date draws income-focused attention

MetLife shares on the NYSE trade near the upper end of their 52-week range as investors track a May 29, 2026 ex-dividend date on the company’s 4.75% Series F preferred shares and reassess the group’s income profile and valuation metrics.

MetLife Inc. stock on the New York Stock Exchange is trading close to the upper end of its 52-week range as investors focus on a key May 29, 2026 ex-dividend date for the insurer’s 4.75% Series F preferred shares and reassess the group’s income profile and valuation metrics.

According to recent trading data, the MetLife share price stood around USD 81.96 on 05/28/2026 on the NYSE, after touching an intraday high of USD 83.17 and a low of USD 81.82 during that session, with the stock roughly 1.5% below its recent high and modestly above the day’s low. Over the past 12 months, the stock has appreciated by about 5% to 7%, with a year-to-date performance in the mid-single-digit percentage range and a 52-week corridor reported between roughly USD 67.33 and USD 85.29. Based on recent quotes, the company’s equity is valued at a market capitalization of around USD 52.7 billion to USD 53.5 billion, and the shares change hands at a price-to-earnings ratio near 16x with a dividend yield close to 2.7% on the common stock. In the United States, MetLife is a constituent of major insurance and financial indices and remains a well-followed name among NYSE-listed large-cap financials.

The immediate news focus for income-oriented investors is the preferred share calendar: MetLife has scheduled a quarterly dividend of USD 0.29688 per depositary share on its 4.75% non-cumulative preferred stock, Series F, with the ex-dividend date set for 05/29/2026 and a record date on the same day, as reported by multiple market news services. Each depositary share corresponds to a fractional interest in a share of the Series F preferred, and the dividend forms part of MetLife’s broader capital-return policy, which combines preferred distributions with common-stock dividends and share repurchases. The preferred announcement complements other recent capital measures, including a fresh quarterly dividend declaration on MetLife’s 5.625% non-cumulative preferred stock, Series E, highlighting a continued emphasis on predictable capital allocation. For German investors, MetLife is also available via secondary trading venues such as Tradegate or Frankfurt, where the stock can be quoted in euro, providing an additional access point alongside the home-market NYSE listing in the United States.

As of: 05/29/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: MetLife Inc.
• Sector/industry: Insurance and financial services
• Headquarters/country: New York, United States
• Core markets: United States, Latin America, Asia, Europe, Middle East and Africa
• Key revenue drivers: Group benefits, retirement and income solutions, individual life and annuities, asset management fees
• Home exchange/listing venue: New York Stock Exchange (MET)
• Trading currency: USD

MetLife Inc.: core business model

MetLife generates most of its revenue by providing insurance, employee benefits and retirement income products worldwide, with earnings largely driven by underwriting margins, investment income on its sizable portfolio and fee-based asset management activities.

Valuation metrics and multiples for MetLife Inc.

With Friday’s module focusing on valuation, investors are looking closely at how the insurer’s current trading multiples compare with both its own history and other large-cap US financials. Recent market data indicate that MetLife’s common shares trade at a price-to-earnings ratio of roughly 16.1x based on the latest reported earnings, while the stock’s dividend yield stands near 2.7% on an annualized basis, reflecting the regular quarterly cash payouts to shareholders. Over the last year, the share price has moved within a 52-week band between about USD 67.33 and USD 85.29, putting the current level near the higher portion of that range but still below the top end, which may suggest that a portion of the recent rerating has already been priced in by the market. The combination of earnings multiple, dividend yield and trading range offers a concise snapshot of how the equity market currently values MetLife’s earnings power and income stream relative to broader US insurance peers and the wider S&P 500 financial cohort.

Beyond simple headline ratios, the valuation picture is also influenced by the company’s capital allocation policy, including its common dividend, preferred dividends and any active share repurchase plans. The scheduled USD 0.29688 per-share dividend on the 4.75% Series F preferred shares and the separate quarterly dividend on the 5.625% Series E preferred stock underline management’s commitment to distributing cash to holders of both common and preferred securities while maintaining regulatory capital buffers appropriate for a global insurer. At the equity level, these capital returns are evaluated alongside balance-sheet strength, interest-rate sensitivity and credit trends in MetLife’s investment portfolio, elements that can all affect how investors apply valuation discounts or premiums relative to peers in the life and retirement sector.

Conclusion

The key near-term focus for MetLife investors is the 05/29/2026 ex-dividend date and associated USD 0.29688 per-share payout on the 4.75% Series F preferred shares, which underscores the company’s emphasis on consistent capital returns alongside its common dividend. In valuation terms, the stock’s current price-to-earnings ratio around 16x, dividend yield near 2.7% and trading level close to the upper part of its 52-week range suggest that the market is already assigning a solid, though not extreme, premium to MetLife’s earnings and income profile relative to broader US financials. How investors balance this income visibility against macro factors such as interest rates, credit trends and regulatory capital requirements will likely determine whether MetLife’s shares continue to consolidate around current levels or adjust as the year progresses.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.